Royal Bank of Canada
BIIB icon

Royal Bank of Canada’s Biogen BIIB Stock Holding History

Royal Bank of Canada’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,200
Closed -$284K – 6865
2019
Q1 		$284K Sell
1,200
-3,700
-76% -$1.17M ﹤0.01% 4127
2018
Q4 		$1.47M Buy
4,900
+800
+20% +$255K ﹤0.01% 2867
2018
Q3 		$1.45M Sell
4,100
-3,300
-45% -$1.14M ﹤0.01% 3084
2018
Q2 		$2.15M Sell
7,400
-34,900
-83% -$9.81M ﹤0.01% 2672
2018
Q1 		$11.6M Buy
42,300
+7,000
+20% +$2.17M 0.01% 1435
2017
Q4 		$11.2M Buy
35,300
+5,000
+17% +$1.6M ﹤0.01% 1528
2017
Q3 		$9.49M Hold
30,300
– – ﹤0.01% 1576
2017
Q2 		$8.22M Sell
30,300
-44,900
-60% -$11.9M ﹤0.01% 1631
2017
Q1 		$20.6M Buy
75,200
+60,100
+398% +$17M 0.01% 1000
2016
Q4 		$4.28M Sell
15,100
-127,700
-89% -$37.9M ﹤0.01% 2060
2016
Q3 		$44.7M Buy
142,800
+95,200
+200% +$28.2M 0.03% 559
2016
Q2 		$11.5M Sell
47,600
-200
-0.4% -$52.7K 0.01% 1359
2016
Q1 		$12.4M Buy
47,800
+15,200
+47% +$4.02M 0.01% 1244
2015
Q4 		$9.99M Buy
32,600
+16,400
+101% +$4.71M 0.01% 1426
2015
Q3 		$4.73M Buy
+16,200
New +$5.35M ﹤0.01% 1616
2015
Q2 		– Sell
-200
Closed -$84K – 6575
2015
Q1 		$84K Buy
+200
New +$78.8K ﹤0.01% 4701
2013
Q3 		– Sell
-1,200
Closed -$258K – 6082
2013
Q2 		$258K Buy
+1,200
New +$256K ﹤0.01% 3690

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada's BIIB Position: Q1 2026 in Review

Royal Bank of Canada reduced its Biogen (BIIB) stake by 1.9% in Q1 2026, selling an estimated $1.93M and leaving 531,377 shares worth $97.4M. The position accounts for 0.02% of the portfolio, ranked #637.

Royal Bank of Canada first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $177M in Q1 2018. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Royal Bank of Canada held 531,377 shares of Biogen worth $97.4M as of Q1 2026.
  • Royal Bank of Canada sold 10,448 Biogen shares in Q1 2026, an estimated $1.93M.
  • Biogen made up 0.02% of Royal Bank of Canada's portfolio in Q1 2026, its #637 holding.
  • Royal Bank of Canada first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Biogen position peaked at $177M in Q1 2018.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.